News

Nanowerk3d
Nanovaccine uses bacterial toxins to trigger immune memory against MRSA
Researchers design a nanovaccine that detects MRSA toxins, kills bacteria with heat, and captures antigens to train the ...
AZoNano3d
Rapid Biomimetic Nanovaccine for Personalized Cancer Therapy
Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, ...
News-Medical.Net4d
Engineered viruses and gene therapy halt tumor growth and extend survival in mice
This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor ...
GV20 Therapeutics Presents Updated Phase 1 Monotherapy Data on GV20-0251 at the ASCO Annual Meeting 2025
GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, today announced that Dr. Kristopher Wentzel ...
C&EN4d
Effective Delivery of Antigen–Encapsulin Nanoparticle Fusions to Dendritic Cells Leads to Antigen-Specific Cytotoxic T Cell Activation and Tumor Rejection
† Department of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 689-798, Korea ‡ Soonchunhyang Institute of Medi-bio Science (SIMS), ...